CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 45.33%

CSPC Innovation Pharmaceutical Co., Ltd. Gross Profit Margin is 45.33% for the year ending December 31, 2023, a 4.91% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

CSPC Innovation Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 43.21%, a -9.78% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 47.90%, a -13.94% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 55.66%, a 8.48% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 51.31%, a 4.52% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years